Select Medical (SEM) Set to Announce Quarterly Earnings on Thursday


Share on StockTwits

Select Medical (NYSE:SEM) is scheduled to be releasing its earnings data after the market closes on Thursday, May 6th. Analysts expect Select Medical to post earnings of $0.65 per share for the quarter. Select Medical has set its FY 2021
After-Hours guidance at 2.26-2.48 EPS and its FY21 guidance at $2.26-2.48 EPS.Persons that are interested in registering for the company’s earnings conference call can do so using this link.

Select Medical (NYSE:SEM) last announced its quarterly earnings results on Thursday, February 25th. The health services provider reported $0.57 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.24 by $0.33. The business had revenue of $1.46 billion for the quarter, compared to analyst estimates of $1.39 billion. Select Medical had a return on equity of 20.22% and a net margin of 3.93%. On average, analysts expect Select Medical to post $2 EPS for the current fiscal year and $2 EPS for the next fiscal year.

Shares of NYSE:SEM opened at $38.22 on Wednesday. The business’s fifty day moving average price is $35.57 and its two-hundred day moving average price is $29.09. The stock has a market cap of $5.15 billion, a PE ratio of 23.89, a price-to-earnings-growth ratio of 1.28 and a beta of 1.47. The company has a debt-to-equity ratio of 2.78, a quick ratio of 1.21 and a current ratio of 1.21. Select Medical has a one year low of $12.83 and a one year high of $38.76.

A number of equities research analysts have commented on the company. Zacks Investment Research cut Select Medical from a “strong-buy” rating to a “hold” rating and set a $40.00 target price on the stock. in a report on Monday. Deutsche Bank Aktiengesellschaft lifted their target price on Select Medical from $27.00 to $34.00 and gave the company a “buy” rating in a report on Wednesday, February 17th. Credit Suisse Group lifted their target price on Select Medical from $32.00 to $34.00 and gave the company a “neutral” rating in a report on Monday, March 8th. Finally, Bank of America upgraded Select Medical from an “underperform” rating to a “buy” rating and lifted their target price for the company from $30.00 to $36.00 in a report on Friday, February 26th.

In other news, Chairman Robert A. Ortenzio sold 300,000 shares of Select Medical stock in a transaction dated Monday, March 1st. The stock was sold at an average price of $32.51, for a total transaction of $9,753,000.00. Also, Director Marilyn B. Tavenner sold 2,000 shares of Select Medical stock in a transaction dated Tuesday, March 9th. The stock was sold at an average price of $33.82, for a total value of $67,640.00. Following the sale, the director now directly owns 28,000 shares in the company, valued at $946,960. The disclosure for this sale can be found here. Insiders sold 414,391 shares of company stock worth $13,662,334 over the last three months. 19.70% of the stock is currently owned by corporate insiders.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. The company's Critical Illness Recovery Hospital segment consists of hospitals that provide services for heart failure, infectious disease, respiratory failure and pulmonary disease, surgery requiring prolonged recovery, renal disease, neurological events, and trauma.

Recommended Story: How can you know how many shares are floating?

Earnings History for Select Medical (NYSE:SEM)

Receive News & Ratings for Select Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Select Medical and related companies with MarketBeat.com's FREE daily email newsletter.